Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa
NCT ID: NCT02002026
Last Updated: 2016-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2013-11-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Internal Iliac Artery Ligation and Abnormally Invasive Placenta
NCT02728232
Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases
NCT03286998
Ligation of Anterior Internal Iliac Artery With Conservative Management of Partial or Focal Placenta Accreta Spectrum
NCT05471102
Bilateral Uterine Artery Ligation in PPC Technique for Management of PAS
NCT05314595
Placenta Accreta; Total Lower Uterine Segmentectomy With Cervico-corporeal Anastomosis
NCT05419804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ligation group
Uterine artery ligation will be done for patients in this group
Uterine artery ligation
Uterine artery ligation during cesarean section before delivery of the baby
Control group
Conventional CS
Uterine artery ligation
Uterine artery ligation during cesarean section before delivery of the baby
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Uterine artery ligation
Uterine artery ligation during cesarean section before delivery of the baby
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic Placenta previa with at least one episode of bleeding
* Estimated gestational age within 28 to 40 weeks
* Maternal age \> 18 years
* Informed consent
* Social affiliation
Exclusion Criteria
* Severe bleeding.
* Abnormal fetal heart rates.
* Pre-eclampsia, chorioamnionitis, severe chronic renal disease.
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia Maternity University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmad Sameer Sanad
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmad S Sameer, MD
Role: PRINCIPAL_INVESTIGATOR
Minia Maternity University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minia Maternity University Hospital
Minya, Minya Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sanad AS, Mahran AE, Aboulfotouh ME, Kamel HH, Mohammed HF, Bahaa HA, Elkateeb RR, Abdelazim AG, El-Din MAZ, Shawki HE. The effect of uterine artery ligation in patients with central placenta pevia: a randomized controlled trial. BMC Pregnancy Childbirth. 2018 Aug 29;18(1):351. doi: 10.1186/s12884-018-1989-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1150-4666
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.